/ /

  • linkedin
  • Increase Font
  • Sharebar

    Lessons learned in adapting EDOF IOLs

     

    Early clinical outcomes

    The average age was 66.4 ± 7.1 years (range age 52 to 79) and 65% of the patients were female. 

    Target refractions ranged from +0.25 D to -0.50 D, with a slightly lower mean target for the non-dominant eyes (-0.20 D, vs. -0.03 D for the dominant eyes). In all, 64% of eyes were within 0.25 D of the intended refractive target, while 83% were within 0.50 D. 

    All eyes had ≤ 0.50 D of residual refractive cylinder at 1 month, with 75% of eyes having 0.0 D of residual cylinder. There was no significant difference in residual cylinder by type of IOL (sphere or toric EDOF).

    The best-corrected distance visual acuity (BCDVA) at 1 month was 0.02 logMAR, or about 1 letter worse than 20/20. No eye had a BCDVA worse than 20/25, and 62.5% had a BCDVA of 20/20 or better. All but 1 eye had 20/20 best-corrected near visual acuity (BCNVA).

    Mean monocular uncorrected distance visual acuity (UCDVA) was 0.15 logMAR, or between 20/25 and 20/30, with a standard deviation of 0.11 logMAR (about 1 line of vision). UCDVA was statistically significantly better (p=0.03) with the Symfony Toric IOL than with the Symfony IOL, by about 1 line (0.11 logMAR or ~20/25 vs. 0.19 logMAR or ~20/30). There was no statistically significant difference in UCDVA between the dominant and non-dominant eyes (p=0.19)Figure 2. Mean monocular UCIVA was 20/20 and UCNVA was 20/30 at 1 month.Mean monocular uncorrected intermediate visual acuity (UCIVA) was 20/20 and near (UCNVA) was 20/30 (See Figure 2). 

    4 things I've learned

    New Call-to-action

    0 Comments

    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available

    Poll

    View Results